These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5057368)

  • 21. The effects of reductions in the numbers of animals used for the potency assay of the diphtheria and tetanus components of adsorbed vaccines by the methods of the European pharmacopoeia.
    Hendriksen CF; van der Gun JW; Marsman FR; Kreeftenberg JG
    J Biol Stand; 1987 Oct; 15(4):353-62. PubMed ID: 3680303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative estimation of diphtheria and tetanus toxoids. 3. Comparative assays in mice and in guinea-pigs of two tetanus toxoid preparations.
    Lyng J; Heron I; Ljungqvist L
    Biologicals; 1990 Jan; 18(1):3-9. PubMed ID: 2317352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral immunization against tetanus.
    Baljer G
    Dev Biol Stand; 1976; 33():63-71. PubMed ID: 955281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M; Komiya T; Fukuda T; Arakawa Y; Takahashi M
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract]   [Full Text] [Related]  

  • 25. Alternative approach and evaluation of three potency assay methods for testing adsorbed tetanus toxoid.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):12-8. PubMed ID: 9842159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental preventive properties of a complex of Pseudomonas aeruginosa and Clostridium tetani anatoxins].
    Podgornaia LG; Dziuban NF; Kalinichenko NF; Isaeva SIa
    Mikrobiol Zh (1978); 1987; 49(5):55-8. PubMed ID: 3150503
    [No Abstract]   [Full Text] [Related]  

  • 27. Local histopathological reactions to aluminum-adsorbed tetanus toxoid.
    Goto N; Akama K
    Naturwissenschaften; 1984 Aug; 71(8):427-8. PubMed ID: 6493343
    [No Abstract]   [Full Text] [Related]  

  • 28. [Evaluation and standardization of tests of tetanus toxoid potency. II. Elaboration of basic parameters of the tests on mice].
    Sawicki J
    Med Dosw Mikrobiol; 1985; 37(3-4):172-8. PubMed ID: 3831629
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and mucosal immune responses of mice to aluminium-adsorbed or aluminium-non-adsorbed tetanus toxoid administered intranasally with recombinant cholera toxin B subunit.
    Isaka M; Yasuda Y; Kozuka S; Miura Y; Taniguchi T; Matano K; Goto N; Tochikubo K
    Vaccine; 1998 Oct; 16(17):1620-6. PubMed ID: 9713937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization against neonatal tetanus in New Guinea. Antitoxin response of pregnant women to adjuvant and plain toxoids.
    MacLennan R; Schofield FD; Pittman M; Hardegree MC; Barile MF
    Bull World Health Organ; 1965; 32(5):683-97. PubMed ID: 5294183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the single dilution test for the EP tetanus toxoid potency assay.
    McKee BL
    Dev Biol Stand; 1999; 101():223-45. PubMed ID: 10566797
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental study on estimating the immunogenic potency of diphtheria and/or tetanus toxoids in monovaccines and associated vaccines.
    Durbacă S; Andronescu C; Diaconescu A
    Roum Arch Microbiol Immunol; 1996; 55(2):119-31. PubMed ID: 9253238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of tetanus vaccines by means of the provided international standard preparation for adsorbed tetanus toxoids].
    Schneider W; Seinsche D
    Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1966; 62():35-44. PubMed ID: 5952862
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental investigations on oral immunization with tetanus-toxoid (author's transl)].
    Baljer G; Starflinger H; Sorg KH; Sailer J; Mayr A
    Zentralbl Bakteriol Orig A; 1975 Aug; 232(4):488-98. PubMed ID: 1199521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acellular pertussis vaccines: evaluation of reversion in a nude mouse model.
    Quentin-Millet MJ; Arminjon F; Danve B; Cadoz M; Armand J
    J Biol Stand; 1988 Apr; 16(2):99-108. PubMed ID: 3259580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Simultaneous prophylaxis against tetanus with tetanus vaccine and human anti-tetanus globulin].
    Züst B
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Mar; 132(3):261-75. PubMed ID: 4232739
    [No Abstract]   [Full Text] [Related]  

  • 39. Standardization of tetanus toxoid combined with pertussis vaccine. II. Some considerations on the standard toxoid for the assay of combined vaccine.
    Yamamoto A; Kondo S; Sadahiro S; Murata R
    Jpn J Med Sci Biol; 1972 Aug; 25(4):281-5. PubMed ID: 4541583
    [No Abstract]   [Full Text] [Related]  

  • 40. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.